Skip to main content
. 2013 Mar 28;15(2):PCC.12f01472. doi: 10.4088/PCC.12f01472

Table 1.

Stimulants: Names, Formulations, and Strengths

Stimulant Generic Name Brand Name Formulations and Strengths Duration of Behavioral Effect (h) Comments
Amphetamines
d-amphetamine Dexedrine Tablets: 5, 10 mg 3–6
Dexedrine Spansules: 5, 10, 15 mg
Spansule
ProCentra Oral solution: 5 mg/5 mL
Mixed amphetamine/dextroamphetamine Adderall Tablets: 5, 7.5, 10, 12.5, 15, 20, 30 mg 4–6
Adderall XR Capsules: 5, 10, 15, 20, 25, 30 mg 8–10 Capsule with 1:1 ratio of immediate-release to delayed-release beads
Lisdexamfetamine dimesylate Vyvanse Capsules: 20, 30, 40, 50, 60, 70 mg Inactive prodrug in which l-lysine is chemically bonded to d-amphetamine
d-methamphetamine Desoxyn Tablet: 5 mg
Methylphenidates
Methylphenidate Ritalin Tablets: 5, 10, 20 mg 3–4
Methylin Tablets, chewable: 2.5, 5, 10 mg 3–4
Oral solution: 5 mg/5 mL, 10 mg/5 mL (500 mL) 3–4
Ritalin sustained release Tablet: 20 mg 5–8
Ritalin LA Capsules: 10, 20, 30, 40 mg 8–9 Capsule with 1:1 ratio of immediate-release beads to delayed-release beads
Metadate ER Tablets: 10, 20 mg 5–8
Metadate CD Capsules: 10, 20, 30 mg 8–9 Capsule with 3:7 ratio of immediate-release beads to delayed-release beads
Concerta Tablets: 18, 27, 36, 54 mg 10–12 Ascending profile, osmotic release oral system technology
Daytrana Transdermal patch: 10, 15, 20, 30 mg/9 h 9 Delivery rate of 1.1, 1.6, 2.2, 3.3 mg/h for the patches, respectively, based on 9-h wear times in patients aged 6–12 y
Quillivant XR Oral suspension: 25mg/5mL 10–12
Dexmethylphenidate Focalin Tablets: 2.5, 5, 10 mg d isomer of methylphenidate, twice as potent as racemic methylphenidate
Focalin XR Capsules: 5, 10, 20 mg